Wessex One Health BBSRC scholarship: Fighting the next global pandemic: Structural characterisation, virtual screening, and translational antifungal testing of novel alternative oxidase (AOX) (2027)

This project is offered as part of our doctoral programme funded by the Biotechnology and Biological Science Research Council (BBSRC). Postgraduate researchers will be trained in interdisciplinary approaches to Infection Biosciences across all classes of pathogens, to combat existing and future disease threats to human and animal health, including emerging infections, vector-borne diseases, antimicrobial resistance and food insecurity.

What you get

PhD studentships cover four years of UK or International PhD fees and a tax free maintenance allowance (currently £21,850  in 2026-7) plus some research costs.

Type of award

PhD scholarship

PhD project

Fighting the next global pandemic: Structural characterisation, virtual screening, and translational antifungal testing of novel alternative oxidase (AOX)

Lead partner: University of Sussex 
Supervisor: Prof Erika Mancini, erika.mancini@sussex.ac.uk

Joint partner: UKHSA
Supervisor: Charlotte Hind, Charlotte.Hind@ukhsa.gov.uk

Project Summary

Multi-drug resistant fungal infections are an escalating global health threat, causing an estimated 6.5 million severe infections each year. Current antifungal medications are rapidly losing efficacy as resistance spreads, creating an urgent need for therapies with novel mechanisms of action. Pathogenic fungi rely on alternative oxidase (AOX), a mitochondrial enzyme upregulated during metabolic stress, to survive standard treatments. Because AOX is absent from the mammalian respiratory chain, it represents an ideal target for selective drug design. However, rational drug development remains constrained by the lack of fungal AOX structures. 

This interdisciplinary project unites protein structural biology, computational drug discovery, and translational pharmacology. Based at the Sussex Drug Discovery Centre, you will be fully integrated into a multidisciplinary environment with access to state-of-the-art facilities, co-supervised by a Medicinal Chemistry expert, Prof John Spencer and mentored from members of the university spin-off Alternox, who bring world-leading expertise in AOX biology. You will express, purify, and solve the first high-resolution 3D structures of fungal AOX using X-ray crystallography and cryo-EM. Using these atomic coordinates, you will conduct virtual screening and structure-based drug design to build libraries of novel inhibitory scaffolds. You will then evaluate direct target engagement using biophysical assays and validate the efficacy of lead compounds in fungal pathogen models to suppress respiration and overcome drug resistance. 

Solving the atomic architecture of fungal AOX will resolve a longstanding bottleneck in the field and accelerate the discovery of first-in-class antifungal therapeutics. This research directly addresses the crisis of antimicrobial resistance by delivering validated chemical matter against a clinically vital target. As a doctoral researcher, you will gain comprehensive, industry-relevant training bridging structural biophysics, computational chemistry, and infection biology, equipping you for leadership roles across academic research and the biotechnology sector.

Eligibility

Who we are looking for

You will have the ambition, motivation and scientific curiosity to research new approaches to combatting infectious diseases in the themes of:

  • Detection, prevention and intervention
  • Microbial evolution and drug resistance
  • Understanding disease spread
  • Infection and cellular biology. 

You will have or expect to have an MSc, and/or a first or upper second honours degree in a relevant subject. We welcome applications from graduates of all universities, and from candidates already in work, or returning after a career break.

Note: Lab experience is desirable but not essential as all successful applicants will be trained in basic lab skills where applicable.

The Scholarships are open to both UK and International applicants.  However international places are limited as 70% of each cohort must be Home Students.  In addition, some of the partner laboratories have nationality or residency requirements due to security clearance checks on their researchers.  Please contact the supervisors for details of any further requirements for this project.

Number of scholarships available

One for this project but 18 PhD studentships are available for October 2027  across the programme. 

Deadline

11 January 2027 12:00

How to apply

Please apply by submitting a Wessex One Health application form and completing our EDI survey.  (not by applying to Sussex in the first instance)

You will find this project listed in Section 14 of the application form.

If you are invited for interview, you should contact the supervisors ahead of the interview, but you are welcome to contact them before applying to find out more about the project.

 

Contact us

For Sussex-specific enquiries contact pgr-scholarships@sussex.ac.uk

For information on this project, contact the Sussex supervisor:  Prof Erika Mancini, erika.mancini@sussex.ac.uk

For further information on the programme or application process, email WOH@surrey.ac.uk.

You might also be interested in

You can find out more about the Wessex One Health Programme here,

Timetable

The timetable is as follows:

  • Submission deadline:  Midday, Monday 11 January 2027
  • Shortlisting: By Friday 12 February 2027
  • Online interviews: Online, week beginning 1 March 2027

 

Availability

At level(s):
PG (research)

Application deadline:
11 January 2027 12:00 (GMT)

Countries

The award is available to people from these specific countries: